Makers Laboratories logo

Makers Laboratories

MAKERSL NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹104 Cr
Volatility
Moderate
P/E Ratio
32.16
EBITDA
₹16.40 Cr
Return on Equity
6.42%
Debt to Equity
0.12
Book Value
₹123.59
52W High
₹236
52W Low
₹150

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has delivered good profit growth of 49.3% CAGR over last 5 years
  • Debtor days have improved from 68.8 to 51.6 days.

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of -2.05% over last 3 years.

Growth Rate

Revenue Growth
7.32% lower than 3Y
Net Income Growth
-27.52% lower than 3Y
Cash Flow Change
450%
ROE
-32.21% lower than 3Y
ROCE
-22.43% higher than 3Y
EBITDA Margin (Avg.)
-24.35% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
25.01
25.06
26.51
27.81
29.59
29.57
27.69
33.9
35
34.17
35.67
35.75
42.77
Expenses
25.15
24.86
26.31
26.95
27.78
27.38
26.38
30.81
31.99
31.89
31.51
30.47
35.81
Operating Profit
-0.14
0.2
0.2
0.86
1.81
2.19
1.31
3.09
3.01
2.28
4.16
5.28
6.96
OPM %
-0.56%
0.8%
0.75%
3.09%
6.12%
7.41%
4.73%
9.12%
8.6%
6.67%
11.66%
14.77%
16.27%
Other Income
0.25
0.41
0.37
0.43
-0.51
10.63
0.87
0.1
0.27
0.36
0.33
0.76
0.61
Interest
0.41
0.49
0.53
0.52
0.49
0.43
0.19
0.18
0.18
0.22
0.2
0.17
0.15
Depreciation
1.11
1.13
1.16
1.15
1.28
1.29
1.31
0.9
1.12
1.13
1.14
1.13
1.13
PBT
-1.41
-1.01
-1.12
-0.38
-0.47
11.1
0.68
2.11
1.98
1.29
3.15
4.74
6.29
Tax %
18.44%
10.89%
-4.46%
152.63%
48.94%
11.98%
60.29%
24.64%
34.85%
42.64%
27.94%
24.89%
27.03%
Net Profit
-1.66
-1.13
-1.06
-0.97
-0.7
9.76
0.27
1.58
1.29
0.74
2.27
3.56
4.59
EPS in Rs
-3.56
-2.27
-2.61
-2.19
-1.66
14.95
-0.51
-0.08
0.75
-0.2
1.59
1.85
2.54
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
69
127
101
104
121
141
148
Expenses
60
108
98
103
112
126
130
Operating Profit
8
19
3
1
9
15
19
OPM %
12%
15%
3.3%
1.1%
7%
11%
13%
Other Income
1
3
2
2
11
2
2
Interest
2
2
2
2
1
1
1
Depreciation
5
4
4
5
5
5
5
PBT
3
16
-1
-4
13
11
15
Tax %
50%
25%
161%
23%
19%
30%
—
Net Profit
1
12
-2
-5
11
8
11
EPS in Rs
-0.56
8.44
-8.05
-10.61
12.69
3.98
5.78
Div. Payout %
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5
5
6
6
6
6
Reserves
49
55
63
57
65
67
Borrowings
21
23
17
22
8
9
Other Liabilities
62
62
66
76
70
85
Total Liabilities
136
144
152
161
148
167
Fixed Assets
71
68
85
87
74
71
CWIP
0
9
0
0
1
4
Investments
2
0
0
3
0
12
Other Assets
63
66
67
71
73
81
Total Assets
136
144
152
161
148
167
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
18
-9
1
-4
14
Investing
0
-22
1
-7
20
-15
Financing
0
0
6
6
-16
0
Net Cash Flow
0
-3
-2
0
0
0
Free Cash Flow
0
9
-21
-6
11
11
CFO/OP
0
128
-185
232
-20
118
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88
39
72
70
85
52
Inventory Days
344
166
281
227
230
250
Days Payable
182
38
91
112
79
110
Cash Conversion Cycle
250
167
262
185
236
192
Working Capital Days
112
61
113
97
140
106
ROCE %
—
15%
1%
-2%
4%
9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Makers Laboratories insights

64 extracted metrics + investor summaries across FY07–FY26.

Log in — free

Shareholding Pattern

DIIs0.39%Promot.61.27%Others6.62%Public31.72%As ofJun 2026

Documents

Frequently Asked Questions about Makers Laboratories

What does Makers Laboratories Ltd do?
Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharma formulations.[1]
Where is Makers Laboratories Ltd (506919) listed?
Makers Laboratories Ltd trades as MAKERSL on the NSE and under code 506919 on the BSE.
Which sector does Makers Laboratories Ltd belong to?
Makers Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the market capitalisation of Makers Laboratories Ltd?
Makers Laboratories Ltd has a market capitalisation of ₹103.85 Cr, which places it in the Small Cap band.
What is the PE ratio of Makers Laboratories Ltd?
Makers Laboratories Ltd trades at a PE ratio of 32.16, against a book value of ₹123.59 per share.
What is the 52-week high and low of Makers Laboratories Ltd?
Over the last 52 weeks Makers Laboratories Ltd has traded between ₹150 and ₹236.
What is the Return on Equity (ROE) of Makers Laboratories Ltd?
Makers Laboratories Ltd reported a return on equity of 6.42%. Its debt-to-equity ratio is 0.12.

Company Information

Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharma formulations.[1]

Website makerslabs.com
Listed 2026-08-17
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506919.md for Makers Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List